MedTrace Logo

Galectin-3 Level in Ankylosing Spondylitis Patients

NCT04746196 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2021-04-20

No results posted yet for this study

Summary

Forty-five AS patients and 35 healthy controls were enrolled in this study. Patients diagnosed with AS according to Modified New York criteria were included in the study. Clinical and laboratory measurements, duration of symptoms, age and body mass index (BMI) of AS patients were performed and compared with age and BMI matched control group.

Conditions

Interventions

OTHER

Serum galectin-3 concentration was measured.

Serum galectin-3 concentration was measured using a commercial chemiluminescent microparticle immunoassay.

Sponsors & Collaborators

  • Recep Tayyip Erdogan University Training and Research Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2017-06-30
Completion
2017-08-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04746196 on ClinicalTrials.gov